tag glycerol fatty acids tag packaged into chylomicrons
play

TAG Glycerol + Fatty Acids TAG (packaged into chylomicrons) - PowerPoint PPT Presentation

Jul 23, 2023 •134 likes •207 views

TAG Glycerol + Fatty Acids TAG (packaged into chylomicrons) Adipose MuscleandHeart Liver(Chylomicronremnants) Fa;yacids+Glycerol Fa;yacids+Glycerol AcetylCoA AcetylCoA

  1. TAG Glycerol + Fatty Acids TAG (packaged into chylomicrons) Adipose
 Muscle
and
Heart
 Liver
(Chylomicron
remnants)
 Fa;y
acids
+
Glycerol
 Fa;y
acids
+
Glycerol
 Acetyl‐CoA
 Acetyl‐CoA
 TCA
and
ETC/Ox.phos
 Fa;y
acids
+
Glycerol
(glycolysis)
 Ketone
 ATP,
CO 2 ,
and
H 2 0
 TAG
(VLDL)
 bodies
 TAG (storage)

  2. O O R C SCoA CH 2 O C R CH 2 OH CHOH CHOH CH 2 OPO 32- CH 2 OPO 32- O R C SCoA O CH 2 O C R O CHO R CH 2 OPO 32- O R C SCoA O CH 2 O C R O CHO R O CH 2 O C R

  4. β ‐OxidaNon:


  5. Lipogenesis‐1st
Round


  6. Lipogenesis‐Subsequent
Rounds


Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend

Disruption of FATB Gene in Arabidopsis Demonstrates an Essential Role of Saturated Fatty Acids in

Disruption of FATB Gene in Arabidopsis Demonstrates an Essential Role of Saturated Fatty Acids in

Disruption of FATB Gene in Arabidopsis Demonstrates an Essential Role of Saturated Fatty Acids in Plant Growth Abby Holden & Nik Wilson acyl-ACP Thioesterase (FAT) - Involved in the release of free fatty acids - Free fatty acids are

858 views • 28 slides
Example: PCA of a matrix of fatty acids in margarines 1.0 C12 0.8 (-0.08 ; 0.72) 0.6 R

Example: PCA of a matrix of fatty acids in margarines 1.0 C12 0.8 (-0.08 ; 0.72) 0.6 R

useR! 2006 Example: PCA of a matrix of fatty acids in margarines 1.0 C12 0.8 (-0.08 ; 0.72) 0.6 R algorithms 0.4 for the calculation of markers to be used 0.2 Latent vector 2 C14 (-0.01 ; 0.19) 0.0 C16 in the construction of

194 views • 4 slides
Lipid Metabolism Lipid nomenclature Oxidation of Fatty acids -oxidation

Lipid Metabolism Lipid nomenclature Oxidation of Fatty acids -oxidation

Lipid Metabolism Lipid nomenclature Oxidation of Fatty acids -oxidation Ketone Bodies Lipid nomenclature Fatty acids triacylglycerols: know structure phospholipids waxes sphingolipids

757 views • 17 slides
Short Chain Fatty Acids Elizabeth Redmond, PhD, MMSc, RD Chair-Elect Dietitians in Integrative

Short Chain Fatty Acids Elizabeth Redmond, PhD, MMSc, RD Chair-Elect Dietitians in Integrative

Assessing Gut Issues: Short Chain Fatty Acids Elizabeth Redmond, PhD, MMSc, RD Chair-Elect Dietitians in Integrative and Functional Medicine DPG Education Specialist, Metametrix Laboratory, Georgia Short Chain Fatty Acids (SFCA) This session

738 views • 49 slides
Omega Fatty Acids Brooke Howard, Jesse Augenstein, Josefina Tomas, Karah Lewis, Keith Valencia,

Omega Fatty Acids Brooke Howard, Jesse Augenstein, Josefina Tomas, Karah Lewis, Keith Valencia,

Omega Fatty Acids Brooke Howard, Jesse Augenstein, Josefina Tomas, Karah Lewis, Keith Valencia, and Sidney Veneris Omega Fatty Acids Definition Carboxyl group with carbon chain Double bonds ALA, DHA, EPA Placement of first

512 views • 13 slides
Medium-chain saturated fatty acids from dairy affect subcutaneous adipose tissue gene expression

Medium-chain saturated fatty acids from dairy affect subcutaneous adipose tissue gene expression

Medium-chain saturated fatty acids from dairy affect subcutaneous adipose tissue gene expression profiles September 8, 2015 Juri Matualatupauw MSc Medium-chain saturated fatty acids C6:0 Liver C8:0 Medium-chain Portal vein C10:0

404 views • 16 slides
Omega ga-3 f fatty a acids a s and car ardiovasc ascular d dise sease se: a con conti

Omega ga-3 f fatty a acids a s and car ardiovasc ascular d dise sease se: a con conti

Omega ga-3 f fatty a acids a s and car ardiovasc ascular d dise sease se: a con conti tinuum o of n nutri riti tion on a and medicine Ann C. Skulas-Ray, PhD Food, Bioactives, & Health Lab Department of Nutritional Sciences

714 views • 24 slides
Disclosures Vitamin D and Omega 3 Fatty Acids: Do They Have Benefits for Mood, Depression, or

Disclosures Vitamin D and Omega 3 Fatty Acids: Do They Have Benefits for Mood, Depression, or

Disclosures Vitamin D and Omega 3 Fatty Acids: Do They Have Benefits for Mood, Depression, or Cognition? Funding from the NIH, Harvard University Royalties (Springer publishing) for book on late life Olivia I. Okereke, MD, SM

192 views • 5 slides
Overview Omega-3 Fatty Acids, Inflammation, and Outcome in Men with and Background &

Overview Omega-3 Fatty Acids, Inflammation, and Outcome in Men with and Background &

Overview Omega-3 Fatty Acids, Inflammation, and Outcome in Men with and Background & Significance without Prostate Cancer Study Objective Study Design & Methods Results Discussion & Conclusions Julie A. Feifers,

397 views • 6 slides
One hour enzymatic synthesis of structural lipid enriched unsaturated fatty acids from

One hour enzymatic synthesis of structural lipid enriched unsaturated fatty acids from

One hour enzymatic synthesis of structural lipid enriched unsaturated fatty acids from silkworm pupa oil under microwave irradiation Fuan Wu School of Biotechnology, Jiangsu University of Science and Technology Sericultural Research

584 views • 17 slides
Omega-3 Fatty Acids as a Prevention Strategy for CAD Deepak L. Bhatt, MD, MPH Executive Director

Omega-3 Fatty Acids as a Prevention Strategy for CAD Deepak L. Bhatt, MD, MPH Executive Director

12/7/19 Omega-3 Fatty Acids as a Prevention Strategy for CAD Deepak L. Bhatt, MD, MPH Executive Director of Interventional Cardiovascular Programs, Brigham and Womens Hospital Heart and Vascular Center Professor of Medicine, Harvard Medical

389 views • 22 slides
Comparisons of pupae oil fatty acids composition and development parameters in a mulberry and

Comparisons of pupae oil fatty acids composition and development parameters in a mulberry and

Comparisons of pupae oil fatty acids composition and development parameters in a mulberry and artificial diet fed insect pest , Spodoptera litura Sheng Sheng shengsheng@just.edu.cn School of biotechnology, Jiangsu University of Science and

513 views • 15 slides
in Dependence on the Plasma Concentration of 37 Fatty Acids After the Coronary Stent Implantation

in Dependence on the Plasma Concentration of 37 Fatty Acids After the Coronary Stent Implantation

Inflammatory Markers in Dependence on the Plasma Concentration of 37 Fatty Acids After the Coronary Stent Implantation Ji Handl , Milan Meloun and Vladimra Mukov University of Pardubice, 532 10 Pardubice, Czech Republic Goal of

543 views • 15 slides
1H qNMR of EPA and DHA Omega-3 Fatty Acids - PLS Regression Models Obtained at 60 and 300 MHz :

1H qNMR of EPA and DHA Omega-3 Fatty Acids - PLS Regression Models Obtained at 60 and 300 MHz :

1H qNMR of EPA and DHA Omega-3 Fatty Acids - PLS Regression Models Obtained at 60 and 300 MHz : At-Line and On-Line Monitroing of a Fish Oil Nutritional Supplement Manufacturing Process John C. Edwards and Paul J. Giammatteo Process NMR

1.24k views • 28 slides
ASCEND A randomized trial of omega-3 fatty acids (fish oil) versus placebo for primary

ASCEND A randomized trial of omega-3 fatty acids (fish oil) versus placebo for primary

ASCEND A randomized trial of omega-3 fatty acids (fish oil) versus placebo for primary cardiovascular prevention in 15,480 patients with diabetes Jane Armitage and Louise Bowman on behalf of the ASCEND Study Collaborative Group Funded by

180 views • 13 slides
ASCEND A randomized trial of omega-3 fatty acids (fish oil) versus placebo for primary

ASCEND A randomized trial of omega-3 fatty acids (fish oil) versus placebo for primary

ASCEND A randomized trial of omega-3 fatty acids (fish oil) versus placebo for primary cardiovascular prevention in 15,480 patients with diabetes Jane Armitage and Louise Bowman on behalf of the ASCEND Study Collaborative Group Funded by

168 views • 14 slides
Prescribing Guidelines 2016 Daniel G. Morris, DO Premier Pain Associates, Inc Board Certified,

Prescribing Guidelines 2016 Daniel G. Morris, DO Premier Pain Associates, Inc Board Certified,

9/13/2016 Prescribing Guidelines 2016 Daniel G. Morris, DO Premier Pain Associates, Inc Board Certified, Fellowship Trained Anesthesiology/Pain Management/Family Practice Disclosure Member of Speakers Bureau: Purdue Eli Lilly

714 views • 11 slides
Opioid Guideline Implementation Workgroup Wednesday, December 5 th , 2018 | 3:00 5:00pm

Opioid Guideline Implementation Workgroup Wednesday, December 5 th , 2018 | 3:00 5:00pm

Opioid Guideline Implementation Workgroup Wednesday, December 5 th , 2018 | 3:00 5:00pm Agenda Welcome and Introductions Action Item: Approve 10/10/2018 Minutes Review Collaborative Care for Chronic Pain Recommendations

850 views • 26 slides
SHIFTING THE APPROACH TO CHRONIC PAIN How to validate, educate, reframe, and collaborate on goals

SHIFTING THE APPROACH TO CHRONIC PAIN How to validate, educate, reframe, and collaborate on goals

SHIFTING THE APPROACH TO CHRONIC PAIN How to validate, educate, reframe, and collaborate on goals David Becker, MD, MPH, MA, LMFT Clinical Professor, UCSF Department of Pediatrics UCSF Osher Center for Integrative Medicine Co-Medical Director,

521 views • 41 slides
Enhancing the patient's' right to avoid pain through the EU network of manager of good practices

Enhancing the patient's' right to avoid pain through the EU network of manager of good practices

Enhancing the patient's' right to avoid pain through the EU network of manager of good practices on chronic pain Mariano Votta , Director of Active Citizenship Network, Bruxelles, 26 April 2018 Good morning everyone. As co-organizer of this

163 views • 3 slides
Treatment Strategies for Dyslipidemia C A S E E X A M P L E S M A R Y M A L L O Y , M D

Treatment Strategies for Dyslipidemia C A S E E X A M P L E S M A R Y M A L L O Y , M D

5/2/15 Treatment Strategies for Dyslipidemia C A S E E X A M P L E S M A R Y M A L L O Y , M D Disclosure I have nothing to disclose 1 5/2/15 CASE 1 41 year old woman referred because her lipids did not respond fully

387 views • 16 slides
Fat, Cholesterol and Genetics 2019 Jacques Genest MD Cardiovascular Health Across the Lifespan

Fat, Cholesterol and Genetics 2019 Jacques Genest MD Cardiovascular Health Across the Lifespan

Fat, Cholesterol and Genetics 2019 Jacques Genest MD Cardiovascular Health Across the Lifespan McGill University Health Center ACC-Rockies 12 March 2019 Chylomicronemia Triglycerides > 10 mmol/L (885 mg/dL) Familial Chylomicronemia Type V

328 views • 5 slides
Role of ezetimibe in targeting residual risk Faculty Disclosure Declaration of financial

Role of ezetimibe in targeting residual risk Faculty Disclosure Declaration of financial

Beyond statins: Role of ezetimibe in targeting residual risk Faculty Disclosure Declaration of financial interests For the last 3 years and the subsequent 12 months: I I have received a research grant(s)/ in kind support A From current

277 views • 16 slides
Disclosures Speaking Honoraria Radiometer (Canada) Nova Biomedical, Draeger

Disclosures Speaking Honoraria Radiometer (Canada) Nova Biomedical, Draeger

Disclosures Speaking Honoraria Radiometer (Canada) Nova Biomedical, Draeger Roche Diagnostics (Canada) Research Support (Reagents, Instrumentation, Travel) Nova Biomedical Abbott Laboratories (Canada) Roche

827 views • 82 slides

More recommend